| Literature DB >> 35502424 |
Yu Hu1, Li-Jun Fan2,3, Yue-Ming Jiang1, Hong Liu4, Hui Yong5, Chong Peng1.
Abstract
Purpose: Neuraxial (spinal and epidural) anesthesia is the cornerstone of ensuring the satisfaction rate of painless delivery; however, whether it prolongs the first stage of labor remains controversial. Although current clinical research results tend to be negative, the conclusions are not convincing due to the lack of basic research. This study was conducted to provide a theoretical reference for this controversy through basic research. Materials andEntities:
Keywords: cAMP; cervical resistance; labor stage; neuraxial anesthesia
Mesh:
Substances:
Year: 2022 PMID: 35502424 PMCID: PMC9056095 DOI: 10.2147/DDDT.S352411
Source DB: PubMed Journal: Drug Des Devel Ther ISSN: 1177-8881 Impact factor: 4.319
Figure 1Norepinephrine (NE) reverses the decrease in cervical tone caused by ropivacaine (Ropi). (A) Schematic diagram of the study timeline. (B and C) One of the load–elongation linear regression results of each group, gray represents the test value of the control group; green represents the control + ropivacaine group; black represents the control + ropivacaine + NE group. The slope of the regression line reflects cervical tension. (D) Compared with the control group, the cervical resistance in the control + ropivacaine group was significantly reduced (**P < 0.01); compared with the control + ropivacaine group, the cervical resistance in the control + ropivacaine + NE group was significantly enhanced (###P < 0.001) (n = 6 for each group).
Cervical Resistance in Each Group (g/mm)
| Groups | N | Mean | Std. Error | 95% Confidence Interval for Mean | |
|---|---|---|---|---|---|
| Lower Bound | Upper Bound | ||||
| Control | 6 | 0.3002 | 0.0178 | 0.2547 | 0.3459 |
| Control + Ropi | 6 | 0.1760 | 0.0105 | 0.1490 | 0.2030 |
| Control + Ropi + NE | 6 | 0.4659 | 0.0178 | 0.4200 | 0.5117 |
| Total | 18 | 0.3140 | 0.0300 | 0.2507 | 0.3774 |
Abbreviations: Ropi, ropivacaine; NE, norepinephrine.
Figure 2α2A adrenergic receptor (α2A-AR) levels and cAMP concentration in the cervical tissue. (A and B) Cervical α2A-AR levels gradually increased over time in pregnant rats, with the expression peaking on day 22 (***P < 0.001) (n = 4 for each group). (C) Compared with the control group, the cervical tissue cAMP concentration in the control + ropivacaine group was significantly increased (**P < 0.01); compared with the control + ropivacaine group, the cervical tissue cAMP concentration in the control + ropivacaine + NE group was significantly reduced (##P < 0.01) (n = 6 for each group).
Cervical cAMP Concentration in Each Group (pmol/mg Tissue)
| Groups | N | Mean | Std. Error | 95% Confidence Interval for Mean | |
|---|---|---|---|---|---|
| Lower Bound | Upper Bound | ||||
| Control | 6 | 40.9817 | 1.11768 | 38.1086 | 43.8548 |
| Control + Ropi | 6 | 49.4117 | 1.51390 | 45.5201 | 53.3033 |
| Control + Ropi + NE | 6 | 31.8467 | 1.91680 | 26.9194 | 36.7740 |
| Total | 18 | 40.7467 | 1.93230 | 36.6699 | 44.8235 |
Abbreviations: Ropi, ropivacaine; NE, norepinephrine.